<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34375156</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2167-9223</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>3-4</Issue><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</Title><ISOAbbreviation>Amyotroph Lateral Scler Frontotemporal Degener</ISOAbbreviation></Journal><ArticleTitle>Predicting dysphagia onset in patients with ALS: the ALS dysphagia risk score.</ArticleTitle><Pagination><StartPage>271</StartPage><EndPage>278</EndPage><MedlinePgn>271-278</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21678421.2021.1961805</ELocationID><Abstract><AbstractText><i>Purpose</i>: For patients diagnosed with ALS, dysphagia can result in aspiration, malnutrition, and mortality. The purpose of this study was to develop a clinical prediction model capable of identifying patients with ALS at imminent risk for developing swallowing complications. <i>Methods</i>: A retrospective cohort study using the Pooled Resource Open-Access ALS Clinical Trials Database (PRO-ACT) was conducted. After dividing the PRO-ACT database into development and validation cohorts with dysphagia defined from the ALS Functional Rating Scale (ALSFRS), a multivariable Cox proportional hazards regression model estimated the probability of dysphagia at 3, 6, and 12-months with subsequent evaluation of model discrimination and calibration. <i>Results</i>: With 2057 participants in the development cohort and 1891 in the validation cohort, the Cox model included 7 clinical variables: spinal-onset; bulbar, fine and gross motor ALSFRS subscale scores; respiratory impairment; functional progression rate; and time from diagnosis. The cumulative incidence of dysphagia was 18% at 3-months, 29% at 6-months, and 45% at 12-months. The mean predicted probability of dysphagia development ranged from 4.5% in the bottommost risk decile to 40% in the topmost decile at 3 months, 10%-72% at 6 months, and 25%-93% at 12 months. In the validation cohort, the model had good discrimination and calibration with an optimism corrected c-statistic of 0.70 and calibration slope of 0.96. <i>Conclusions</i>: The ALS dysphagia risk score can be used to identify patients with ALS at high risk for self-reported dysphagia development who would benefit from a comprehensive swallowing assessment and proactive dysphagia management strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>Bridget J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Clinical and Translational Sciences Institute, Tufts Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Communication Sciences and Disorders, MGH Institute of Health Professions, Charlestown, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nelson</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinical and Translational Sciences Institute, Tufts Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Predictive Analytics and Comparative Effectiveness (PACE) Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>J B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Division of Clinical Decision Making, Department of Medicine, Tufts Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kent</LastName><ForeName>D M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Clinical and Translational Sciences Institute, Tufts Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Predictive Analytics and Comparative Effectiveness (PACE) Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Pooled Resource Open-Access ALS Clinical Trials Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>TL1 TR002546</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002544</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Amyotroph Lateral Scler Frontotemporal Degener</MedlineTA><NlmUniqueID>101587185</NlmUniqueID><ISSNLinking>2167-8421</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003680" MajorTopicYN="Y">Deglutition Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Dysphagia</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">survival</Keyword><Keyword MajorTopicYN="N">swallowing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>10</Day><Hour>17</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34375156</ArticleId><ArticleId IdType="mid">NIHMS1847381</ArticleId><ArticleId IdType="pmc">PMC9782713</ArticleId><ArticleId IdType="doi">10.1080/21678421.2021.1961805</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Perry BJ, Nelson J, Wong J, Kent D The cumulative incidence of dysphagia and dysphagia-free survival in person&#x2019;s diagnosed with Amyotrophic Lateral Sclerosis.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8217360</ArticleId><ArticleId IdType="pubmed">33851421</ArticleId></ArticleIdList></Reference><Reference><Citation>Plowman EK, Tabor LC, Wymer J, Pattee G. The evaluation of bulbar dysfunction in amyotrophic lateral sclerosis: survey of clinical practice patterns in the United States. Amyotroph Lateral Scler Front Degener. 2017;18(5&#x2013;6):351&#x2013;357. doi:10.1080/21678421.2017.1313868</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1313868</ArticleId><ArticleId IdType="pmc">PMC7001984</ArticleId><ArticleId IdType="pubmed">28425762</ArticleId></ArticleIdList></Reference><Reference><Citation>Waito AA, Valenzano TJ, Peladeau-Pigeon M, Steele CM. Trends in Research Literature Describing Dysphagia in Motor Neuron Diseases (MND): A Scoping Review. Dysphagia. 2017;32(6):734&#x2013;747. doi:10.1007/s00455-017-9819-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00455-017-9819-x</ArticleId><ArticleId IdType="pmc">PMC5724560</ArticleId><ArticleId IdType="pubmed">28664472</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogus-Pulia NM, Plowman EK. Shifting tides toward a proactive patient-centered approach in dysphagia management of neurodegenerative disease. Am J Speech-Language Pathol. 2020;29(2S):1094&#x2013;1109. doi:10.1044/2020_AJSLP-19-00136</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/2020_AJSLP-19-00136</ArticleId><ArticleId IdType="pmc">PMC7844336</ArticleId><ArticleId IdType="pubmed">32650651</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattee GL, Plowman EK, Brooks BR, et al. Best practices protocol for the evaluation of bulbar dysfunction: summary recommendations from the NEALS bulbar subcommittee symposium. Amyotroph Lateral Scler Front Degener. 2018;19(3&#x2013;4):311&#x2013;312. doi:10.1080/21678421.2017.1404109</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1404109</ArticleId><ArticleId IdType="pubmed">29205054</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesti E, Schettino I, Gori MC, et al. Dysphagia in Amyotrophic Lateral Sclerosis: Impact on Patient Behavior, Diet Adaptation, and Riluzole Management. Front Neurol. 2017;8:94. doi:10.3389/fneur.2017.00094</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00094</ArticleId><ArticleId IdType="pmc">PMC5359548</ArticleId><ArticleId IdType="pubmed">28377742</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapin JL, Gray LT, Vasilopoulos T, et al. Diagnostic utility of the amyotrophic lateral sclerosis functional rating scale-revised to detect pharyngeal dysphagia in individuals with amyotrophic lateral sclerosis. PLoS One. Published online 2020. doi:10.1371/journal.pone.0236804</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0236804</ArticleId><ArticleId IdType="pmc">PMC7425890</ArticleId><ArticleId IdType="pubmed">32790801</ArticleId></ArticleIdList></Reference><Reference><Citation>Atassi N, Berry J, Shui A, et al. The PRO-ACT database: design, initial analyses, and predictive features. Neurology. 2014;83(19):1719&#x2013;1725. doi:10.1212/WNL.0000000000000951</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000951</ArticleId><ArticleId IdType="pmc">PMC4239834</ArticleId><ArticleId IdType="pubmed">25298304</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong P, Yunusova Y, Wang J, et al. Predicting Speech Intelligibility Decline in Amyotrophic Lateral Sclerosis Based on the Deterioration of Individual Speech Subsystems. PLoS One. 2016;11(5):e0154971. doi:10.1371/journal.pone.0154971</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0154971</ArticleId><ArticleId IdType="pmc">PMC4858181</ArticleId><ArticleId IdType="pubmed">27148967</ArticleId></ArticleIdList></Reference><Reference><Citation>Luchesi KF, Kitamua S, Mour&#xe3;o LF. Amyotrophic Lateral Sclerosis survival analysis: Swallowing and non-oral feeding. NeuroRehabilitation. 2014;35(3):535&#x2013;542. doi:10.3233/NRE-141149</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/NRE-141149</ArticleId><ArticleId IdType="pubmed">25238863</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackrivo J, Hansen-Flaschen J, Wileyto EP, Schwab RJ, Elman L, Kawut SM. Development of a prognostic model of respiratory insufficiency or death in amyotrophic lateral sclerosis. Eur Respir J. 2019;53(4). doi:10.1183/13993003.02237-2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02237-2018</ArticleId><ArticleId IdType="pmc">PMC6684229</ArticleId><ArticleId IdType="pubmed">30728207</ArticleId></ArticleIdList></Reference><Reference><Citation>Proudfoot M, Jones A, Talbot K, Al-Chalabi A, Turner MR. The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onset. Amyotroph Lateral Scler Front Degener. 2016;17(5&#x2013;6):414&#x2013;425. doi:10.3109/21678421.2016.1140786</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1140786</ArticleId><ArticleId IdType="pmc">PMC4950444</ArticleId><ArticleId IdType="pubmed">26864085</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin DB, Wiley J, York N, Brisbane C, Singapore T. Multiple Imputation for Nonresponse in Surveys; 1987. Accessed September 27, 2018. 10.1002/9780470316696.fmatter</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9780470316696.fmatter</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrell FE. Regression Modeling Strategies. Springer; New York; 2001. doi:10.1007/978-1-4757-3462-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4757-3462-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrell FE. Regression Modeling Strategies. Springer International Publishing; 2015. doi:10.1007/978-3-319-19425-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-19425-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyerberg EW. Clinical Prediction Models - A Practical Approach to Development, Validation, and Updating. Second. Springer; 2019. Accessed December 8, 2020. https://www.springer.com/us/book/9783030163983</Citation></Reference><Reference><Citation>Vickers AJ, van Calster B, Steyerberg EW. A simple, step-by-step guide to interpreting decision curve analysis. Diagnostic Progn Res. Published online 2019. doi:10.1186/s41512-019-0064-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41512-019-0064-7</ArticleId><ArticleId IdType="pmc">PMC6777022</ArticleId><ArticleId IdType="pubmed">31592444</ArticleId></ArticleIdList></Reference><Reference><Citation>Vickers AJ, Elkin EB. Decision Curve Analysis: A Novel Method for Evaluating Prediction Models. Med Decis Mak. 2006;26(6):565&#x2013;574. doi:10.1177/0272989X06295361</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0272989X06295361</ArticleId><ArticleId IdType="pmc">PMC2577036</ArticleId><ArticleId IdType="pubmed">17099194</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. No Title. R Foundation for Statistical Computing; 2017. https://www.r-project.org/</Citation></Reference><Reference><Citation>Pinto S, Gromicho M, De Carvalho M. Sialorrhoea and reversals in ALS functional rating scale. J Neurol Neurosurg Psychiatry. 2017;88(2):187&#x2013;188. doi:10.1136/jnnp-2016-313614</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-313614</ArticleId><ArticleId IdType="pubmed">27634984</ArticleId></ArticleIdList></Reference><Reference><Citation>Plowman EK, GJ R, G L, et al. Is There a Role for Exercise in the Management of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis? J Speech Lang Hear Res. 2015;58(4):1151&#x2013;1166. doi:10.1044/2015_JSLHR-S-14-0270</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/2015_JSLHR-S-14-0270</ArticleId><ArticleId IdType="pubmed">26091205</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler SG, Stuart A, Leng X, et al. The Relationship of Aspiration Status With Tongue and Handgrip Strength in Healthy Older Adults. Journals Gerontol Ser A Biol Sci Med Sci. 2011;66A(4):452&#x2013;458. doi:10.1093/gerona/glq234</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glq234</ArticleId><ArticleId IdType="pmc">PMC3107020</ArticleId><ArticleId IdType="pubmed">21300744</ArticleId></ArticleIdList></Reference><Reference><Citation>Hathaway B, Baumann B, Byers S, Wasserman-Wincko T, Badhwar V, Johnson J. Handgrip strength and dysphagia assessment following cardiac surgery. Laryngoscope. 2015;125(10):2330&#x2013;2332. doi:10.1002/lary.25175</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.25175</ArticleId><ArticleId IdType="pubmed">26108961</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleming TR, DeMets DL. Surrogate End Points in Clinical Trials: Are We Being Misled? Ann Intern Med. Published online 1996. doi:10.7326/0003-4819-125-7-199610010-00011</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-125-7-199610010-00011</ArticleId><ArticleId IdType="pubmed">8815760</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>